CoChat

Akt2 knockout preserves cardiac function in high-fat diet-induced obesity by rescuing cardiac autophagosome maturation

Open access
Xu, Xihui, Hua, Yinan, Sreejayan, Nair, Zhang, Yingmei, Ren, Jun · 2013 · Journal of Molecular Cell Biology
Cited by 135

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Dear Editor, Accumulating studies have demonstrated that the autophagy–lysosome pathway, a major pathway governing protein and organelle degradation and recycling, is a house keeper in cardiomyocytes under physiological conditions (Mizushima and Klionsky, 2007). However, the role of autophagy in the heart under pathological conditions is still controversial (Nemchenko et al., 2011). In vivo studies depicted that inhibition of mammalian target of rapamycin (mTOR), a primary inhibitory regulator of autophagy, is capable of attenuating pressure overload-induced cardiac dysfunction (McMullen et al., 2004). To the contrary, recent studies have also indicated that suppressing autophagy is beneficial for cardiac hypertrophy (Cao et al., 2011). Along the same line, activated autophagy has been proved detrimental for pressure overload-induced heart failure (Zhu et al., 2007). However, the role of autophagy in the heart in high-fat diet (HFD)-induced obesity is poorly understood. To date, there is little evidence suggesting a role of autophagy in heart anomalies associated with diet-induced obesity, although a number of upstream regulators of autophagy have been identified to play a role in HFD-induced obesity. For example, the primary inhibitor of autophagy mTOR may be hyperactivated by an HFD and contribute to the development of cardiac dysfunction (Birse et al., 2010). As the major activator of mTOR, the Akt family of serine–threonine kinases is also activated by an HFD in the heart. However, the precise role of Akt2, one of the three Akt isoforms predominantly found in the heart, in autophagy regulation in HFD-induced obesity still remains elusive. To this end, the present study was designed to evaluate the role of autophagy and autophagy flux in HFD feeding-induced cardiac geometric and functional changes with a special focus on Akt2 signaling. HFD intake significantly increased body and organ (heart, liver, kidney and adipose tissue) weights compared with low-fat diet (LFD) feeding (Supplementary Table S2). Western blot analysis confirmed the absence of Akt2 in hearts from Akt2−/− mice (Supplementary Figure S1A and B). Interestingly, HFD feeding upregulated cardiac expression of Akt2 (Supplementary Figure S1A and B) but not that of Akt1 (Supplementary Figure S7A and B) and Akt3 (Supplementary Figure S7A and C). Akt2 knockout did not affect body or organ weight in LFD-fed mice (Supplementary Table S2). However, Akt2 knockout effectively nullified HFD-induced gain in body and organ/tissue weights, in particular the heart (Supplementary Table S2). Accumulating studies have demonstrated that Akt regulates cell growth and lipid biosynthesis through mTORC1. Accordingly, we found that an HFD-activated Akt (Supplementary Figure S6A and B) and mTORC1 (Supplementary Figure S7A and I) in the heart, both of which were mitigated by Akt2 knockout. These data depict a beneficial effect of Akt2 knockout against HFD-induced weight gain possibly through the inhibition of Akt-mTORC1 activation. In addition, HFD feeding significantly increased the level of triglyceride, the effect of which was ablated by Akt2 knockout (Supplementary Figure S1C). Further scrutiny of glucose metabolism using intraperitoneal glucose tolerance test revealed overt glucose intolerance following HFD intake in the wild type (WT) which was partially attenuated in the Akt2−/− mice (Supplementary Figure S1D and E). HFD feeding significantly compromised myocardial geometry and function as evidenced by overtly increased LV ESD, LV EDD and LV mass, as well as decreased fractional shortening associated with unchanged septum and posterior wall thickness. Interestingly, Akt2 knockout ameliorated HFD feeding-induced cardiac geometric and contractile anomalies (Figure 1A and B and Supplementary Figure S2A–E). Further assessment of cardiomyocyte contractile function revealed consistent findings. HFD feeding dampened cardiomyocyte contractile capacity (decreased peak shortening and maximal velocity of shortening/re-lengthening) associated with unchanged duration of shortening and re-lengthening, which was recovered by Akt2 knockout (Figure 1C and D and Supplementary Figures S2F–I and Supplementary DataA–C). Besides, Akt2 knockout significantly ameliorated intracellular Ca2+ handling dysfunction induced by an HFD in the WT mice (Supplementary Figure S2J–O). Additionally, HFD feeding induced cardiac hypertrophy (Supplementary Figure S4A–H), interstitial fibrosis (Supplementary Figure S5A and B), and activated cardiac protein synthesis pathway (Supplementary Figures S6A–K and Supplementary DataA, J, and K), which were obliterated by Akt2 knockout. Taken together, these results supported that Akt2 knockout protected murine hearts against HFD-induced cardiac pathological hypertrophy. Akt2 knockout preserves cardiac function in HFD-induced obesity by rescuing cardiac autophagosome maturation. (A and B) Fractional shortening (FS, %) and LV-end systolic diameter (LVESD) of th

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/jmcb/mjs055

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 135

Metadata

Authors
Xu, X., Hua, Y., Sreejayan, N., Zhang, Y., & Ren, J.
Venue
Journal of Molecular Cell Biology
Published
2012-12-19
Volume
5
Issue
1
Pages
61-63
ISSN
  • 1674-2788 (ISSN-L)
  • 1759-4685
OpenAlex
W1987240861
Cited by
135
References
2
FWCI
9.48
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.